Oxytocin Substitution Therapy in Patients With Central Diabetes Insipidus

Condition:   Central Diabetes Insipidus (cDI) Interventions:   Drug: Intranasal OXT;   Other: Placebo nasal spray Sponsor:   University Hospital, Basel, Switzerland Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials